Reynolds American Inc. on Monday cleared the final hurdle for its $25 billion acquisition of Lorillard Inc. as a federal judge granted approval allowing the company to go forward with its plan to divest several cigarette brands.
US District Judge Gladys Kessler of Washington, DC, granted a motion that will allow Reynolds to divest Maverick, Kool, Salem and Winston cigarette brands to Imperial Tobacco Group PLC. The divestiture of those brands, which will cost Imperial $7.1 billion, was critical to Federal Trade Commission approval of the deal.
The companies needed judicial approval for that divestiture because they are subject to a nearly decade-old civil judgment in a government racketeering case that requires they obtain court permission before they can divest cigarette brands.
Reynolds and Lorillard announced their planned marriage last July. The agreement included the Imperial divestiture, which was designed to head off concerns the merger would hurt competition and lead to higher prices.
The FTC, which spent nearly a year scrutinizing the deal, granted approval for it late last month. Reynolds has said it expects to close the deal in June.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas